Miriam Redrado

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Glycemic Control

Combination Therapy

Tyrosine Kinase

Metastatic Renal Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Clément Anfray, Francesco Mainini, Elisabeth Digifico, Akihiro Maeda, Marina Sironi, Marco Erreni, Achille Anselmo, Aldo Ummarino, Sara Gandoy, Francisco Expósito, Miriam Redrado, Diego Serrano, Alfonso Calvo, Marvin Martens, Susana Bravo, Alberto Mantovani, Paola Allavena, Fernando Torres Andón
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for immunotherapy of cancer 9 (9) (2022)
Esther Redin, Irati Garmendia, Teresa Lozano, Diego Serrano, Yaiza Senent, Miriam Redrado, Maria Villalba, Carlos E De Andrea, Francisco Expósito, Daniel Ajona, Sergio Ortiz-Espinosa, Ana Remirez, Cristina Bertolo, Cristina Sainz, Juana Garcia-Pedrero, Ruben Pio, Juan Jose Lasarte, Jackeline Agorreta, Luis M Montuenga, Alfonso Calvo
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for immunotherapy of cancer 9 (3) (2021)
Emilio Esteban, Francisco Expósito, Guillermo Crespo, Julio Lambea, Alvaro Pinto, Javier Puente, Jose A Arranz, Miriam Redrado, Cristina Rodriguez-Antona, Carlos de Andrea, Marta Lopez-Brea, Esther Redin, Angel Rodriguez, Jorge G González, Jorge Garcia, Enrique Grande, Daniel Castellano, Alfonso Calvo
Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers 13 (11) (2021)